Visugromab
Product Specifications
CAS Number
2556646-63-8
Target
PD-1/PD-L1, TGF-beta/Smad
Related Pathways
Apoptosis, Stem Cells, Cell Cycle/Checkpoint, Immunology/Inflammation
Purity
0.988
Bioactivity
Visugromab (CTL-002) is a monoclonal antibody that targets and neutralises GDF-15. Visugromab exhibits synergistic anticancer activity with the anti-PD1 antibody Nivolumab, making it suitable for PD-1/PD-L1 recurrent/refractory metastatic solid tumours.
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS7231251-01 48 Well
Rat Arf-GAP domain and FG repeats-containing protein 2 (AGFG2) ELISA Kit
Sign In for Pricing
View Details MBS7231251-02 96 Well
Rat Arf-GAP domain and FG repeats-containing protein 2 (AGFG2) ELISA Kit
Sign In for Pricing
View Details MBS7231251-03 5x 96 Well
Rat Arf-GAP domain and FG repeats-containing protein 2 (AGFG2) ELISA Kit
Sign In for Pricing
View Details MBS7231251-04 10x 96 Well
Rat Arf-GAP domain and FG repeats-containing protein 2 (AGFG2) ELISA Kit
Sign In for Pricing
View Details GTR15136077 1 Vial
Lentiviral human GLI2 shRNA (UAS) - Lentiviral human GLI2 shRNA (UAS, GFP) (100)
Sign In for Pricing
View Details